PRKD1 and breast cancer: We assessed the methylation status over a stretch of 32 CpG sites of the PRKD1 promoter by bisulfite sequencing in a subset of highly invasive and non- or minimally invasive breast cancer cell lines as well as in the “normal” MCF-10A cells (Figure 1B).